Related references
Note: Only part of the references are listed.Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms
Amy V. Jonesa et al.
LEUKEMIA RESEARCH (2015)
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination
Wendy T. Parker et al.
BLOOD (2014)
The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants
Ayalew Tefferi et al.
BLOOD (2014)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg et al.
BLOOD (2014)
JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort
Gillian McGaffin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype
A. Tefferi et al.
LEUKEMIA (2014)
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease
A. Kohlmann et al.
LEUKEMIA (2014)
Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications
Vera Grossmann et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories
A. Kohlmann et al.
LEUKEMIA (2011)
Share Paper
